HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12044 | 14455 | 83.3% | |
| HF 4 | 2011 | 12158 | 14356 | 84.7% | |
| HF 4 | 2012 | 13507 | 15878 | 85.1% | |
| HF 4 | 2013 | 14713 | 16828 | 87.4% | |
| HF004(S) | 2014 | 7563 | 8199 | 92.2% | |
| HF004(S) | 2015 | 9480 | 10284 | 92.2% | |
| HF004(S) | 2016 | 11013 | 12049 | 91.4% |
